The Western blot results showed that leptin-induced MTA1 upregulation was suppressed by all these inhibitors (Figure 2), confirming that leptin regulates MTA1 expression via the Ob-R/STAT3 signaling pathway in breast cancer cells. Here, LEPR is linked to breast carcinoma.